ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$65.73
+5.44% today
Updated 2026-04-30
Market cap
$1.81B
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$11 – $72
Volume
0.6M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A7.0
Quality
B+5.0
Profitability
C+6.7
Valuation
B4/9
Piotroski F-Score
Moderate
-0.3
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$78.92
+20.07%
12-Month target
—
—
Intrinsic (DCF)
$411.61
Margin of safety
+86.58%
3 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $98.00M — positive
+ Revenue growth 151.10% QoQ
+ 86.58% below intrinsic value
+ Debt/equity -11.78x — low leverage
Risks
- Altman Z -0.32 — distress zone
- Thin margins at -5.64%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $10.29M | $17.16M | $91.28M | $234.60M | $234.60M |
| Net income | $-128.72M | $-163.62M | $-145.23M | $-13.23M | $49.61M |
| EPS | — | — | — | — | $-0.46 |
| Free cash flow | $-73.95M | $-121.61M | $-135.69M | $19.61M | $98.00M |
| Profit margin | -1,251.33% | -953.66% | -159.10% | -5.64% | -5.64% |
Peer comparison
Smart narrative
AnaptysBio Inc trades at $65.73. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.32, it sits in the distress. TTM revenue stands at $234.60M. with profit margins at -5.64%. Our DCF model estimates intrinsic value at $411.61.
Frequently asked questions
What is AnaptysBio Inc's stock price?
AnaptysBio Inc (ANAB) trades at $65.73.
Is AnaptysBio Inc overvalued?
Smart Value Score 41/100 (Grade D, Sell). DCF value $411.61.
What is the price target of AnaptysBio Inc (ANAB)?
The analyst target price is $78.92, representing +20.1% upside from the current price of $65.73.
What is the intrinsic value of AnaptysBio Inc (ANAB)?
Based on our DCF model, intrinsic value is $411.61, a +86.6% margin of safety versus $65.73.
What is AnaptysBio Inc's revenue?
TTM revenue is $234.60M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-0.32 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio7.73x
ROE-24.50%
Beta0.41
50D MA$43.48
200D MA$28.33
Shares out0.03B
Float0.02B
Short ratio—
Avg volume0.6M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—